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Pediatric low-grade gliomas (LGGs) frequently do not en-
graft in immunocompromised mice, limiting their use as
an experimental platform. In contrast, murine Neuro-
fibromatosis-1 (Nf1) optic LGG stem cells (o-GSCs)
form glioma-like lesions in wild-type, but not athymic,
mice following transplantation. Here, we show that the
inability of athymic mice to support o-GSC engraftment
results from impaired microglia/macrophage function,
including reduced expression of Ccr2 and Ccl5, both of
which are required for o-GSC engraftment and Nf1 optic
glioma growth. Impaired Ccr2 and Ccl5 expression in
athymic microglia/macrophages was restored by T-cell
exposure, establishing T-cell–microglia/macrophage in-
teractions as critical stromal determinants that support
NF1 LGG growth.
Supplemental material is available for this article.
Received December 12, 2017; revised version accepted
March 13, 2018.
Immunocompromisedmice (e.g., athymic Foxn1−/−mice)
are common tools for human tumor xenograft studies, in-
cluding high-grade gliomas (Morton and Houghton 2007;
Venkatesh et al. 2017).Whilemalignant glioma stem cells
readily form tumors in athymicmice, no successful ectop-
ic xenografts have been reported for low-grade glioma
(LGG) cells (Raabe et al. 2011). One of the critical determi-
nants of LGG formation and growth is a permissivemicro-
environment composed of nonneoplastic cells, including
immune system cells. This dependency on immune
system-like cells is highlighted by the high percentage
(35%–50%) of Iba1+ microglia/macrophages (Simmons
et al. 2011) as well as increased numbers of T cells in these
tumors (Yang et al. 2011; Griesinger et al. 2013).
Since relative immunodeficiency is required to accept
human cells for rodent xenografting studies and since no
validated human LGG lines are currently available, genet-
ically engineered mouse (GEM) models of pediatric LGGs
have served as experimental platforms to define the role of
immune system-like cells in LGG pathogenesis. To this
end, Neurofibromatosis-1 (Nf1) GEM strains have been
used to define the conditions critical for optic gliomas
(grade I pilocytic astrocytomas [PAs]) arising in the NF1
brain tumor predisposition syndrome (Bajenaru et al.
2003; Zhu et al. 2005). Unlike grade II LGGs, which can
progress to high-grade gliomas, NF1-associated pediatric
LGGs do not transform into malignant gliomas (Hoyt
and Baghdassarian 1969) and rarely result in reduced life
expectancy.
Consistent with a critical role for immune system cells
(monocytes) in Nf1 optic glioma formation and mainte-
nance, genetic Cx3cr1 reduction delays tumor formation
(Pong et al. 2013), and genetic elimination of CD11b+
microglia/macrophages (Simmons et al. 2011) or phar-
macological microglial inhibition (Daginakatte and
Gutmann 2007; Daginakatte et al. 2008) reduces optic gli-
oma proliferation. Moreover, murine Nf1 optic glioma-
associated microglia express the Ccl5 chemokine such
that neutralizing Ccl5 antibodies attenuates optic glioma
growth in vivo (Solga et al. 2015).
Within these murineNf1 optic gliomas are cancer stem
cells, termed optic glioma stem cells (o-GSCs), which are
capable of self-renewal, multilineage differentiation, and
the generation of glioma-like lesions following transplan-
tation into the brain stems of naïve immunocompetent
wild-type mice (Chen et al. 2015). Interestingly, o-GSCs
do not form tumors in immunocompromised athymic
(Foxn1−/−) mice, suggesting that these T-cell-defective
mice lack a microenvironment supportive of o-GSC
engraftment. To define the etiologies for the failure of
o-GSCs to engraft in athymic mice, we demonstrate for
the first time that athymic mice have impaired brain
microglia/macrophage function (phagocytosis and lipo-
polysaccharide [LPS]-mediated cytokine production) as
well as reduced expression of Ccr2 and Ccl5 relative to
their wild-type counterparts. Consistent with a key role
for Ccr2 and Ccl5 in gliomagenesis and optic glioma
maintenance, o-GSCs do not form glioma-like lesions in
either Ccr2- or Ccl5-deficient mice, and treatment with
Ccl2-neutralizing antibodies attenuates Nf1 optic glioma
growth in vivo. In addition, exposure of athymic mouse
brain microglia to activated, but not naïve, wild-type T
cells or T-cell-conditioned medium is sufficient to restore
normal microglial Ccr2 and Ccl5 expression. Taken
together, these observations establish an obligate role
for T cells in monocyte-mediated stromal support of Nf1
LGG pathogenesis.
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Results and Discussion
Athymic mice reveal defects in microglia/macrophages
Because athymic mice lack Foxn1 expression, we first
sought to determine whether Foxn1 loss might alter the
composition of brain stromal cells previously implicated
in glioma maintenance. We focused on the brain stem,
as this is the second most common region for glioma
formation in children with NF1 (Mahdi et al. 2017) and
represents a location suitable for tumor cell engraftment
studies (Chen et al. 2015). In contrast to findings in
athymic BALB/c mice (Htain et al. 1994), we observed
no differences in astrocyte (GFAP+ cell) (Supplemental
Fig. S1A), endothelial cell (CD34+ cell) (Supplemental
Fig. S1B), oligodendrocyte precursor (Olig2+ cell) (Supple-
mental Fig. S1C), or myeloid cell (resident microglia
and peripheral monocyte/macrophage; Iba1+ cell) (Fig.
1A) content in C57BL/6 athymic mouse brain stems rela-
tive to strain-matched wild-type counterparts.
Interestingly, athymic mice harbored an increased per-
centage of amoeboid-shaped Iba1+ cells (Fig. 1A), sugges-
tive of an altered functional state. However, Foxn1 is
expressed primarily in the thymus and skin (Nehls et al.
1994) and not in the mouse or human brain or MACS-iso-
lated microglia/macrophages (Supplemental Fig. S1D–G).
Foxn1 mutation can increase Foxp3+ regulatory T-cell
content (Albuquerque et al. 2012; Oh et al. 2017), but no
Foxp3+ cells were detected in either wild-type or athymic
mouse brain stems (Supplemental Fig. S1H). The absence
of T cells in the naïve mouse brain prompted a further ex-
ploration of Foxn1−/− microglia/macrophage properties.
Using Cx3cr1+/GFP and Ccr2+/RFP reporter mice, we
and others have demonstrated that brain monocytes
(Iba1+ cells) can be either resident brain microglia
(Cx3cr1+Ccr2−) or peripheral macrophages (Ccr2+) (Fig.
1B). In this regard, ∼95% of the brain monocytes are
resident brain microglia (Cx3cr1+Ccr2−), while the rest
are likely peripheral macrophages (Ccr2+) (Mizutani
et al. 2012).
To define the impact of Foxn1 mutation on microglia,
we first examined the expression of transcripts previously
implicated in microglia/macrophage function, including
inflammatory mediators (Nos2, Tnf, Arg1, and Il10), che-
mokine receptors (Cx3cr1 and Ccr2), and genes involved
in microglia/macrophage homeostasis (Cap1, Erg1,
P2ry12, and Tmem119). While no differences in Cap1,
Erg1, or P2ry12 expression were detected (data not
shown), Nos2, Tnf, Arg1, Il10, Tmem119, Cx3cr1, and
Ccr2 expression was reduced in the brain stems of
athymic, relative to wild-type, mice (Fig. 1C). This reduc-
tion was also observed in acutely isolated CD11b+ cells
using magnetic-activated cell sorting (MACS) (Fig. 2A),
where the percentages of CD11b+ cells were similar in
wild-type and athymic brain stems (Fig. 2B). Additionally,
the expression of several antigen presentation-related
genes (Ifng, Cd80, and Cd86) was reduced in isolated
athymic mouse brain microglia/macrophages relative to
their wild-type counterparts (Fig. 2C).
Second, based on reduced baseline Tnf and Il10 expres-
sion in athymicmousemicroglia, we next sought to deter-
minewhether Foxn1−/−microglia have impairedTnfα and
Il10 protein production following LPS stimulation. Con-
sistent with a defect in microglia function, reduced Tnfα
and Il10 levels were detected in the culture medium
(CM) of athymic mouse microglia relative to their wild-
type counterparts (Fig. 2D).
Third, we determined the in situ phagocytic activity
of Foxn1−/− microglia. Under both basal conditions and
following UDP stimulation, athymic mouse microglia
A B
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Figure 1. Athymic mice reveal morphological defects in microglia.
(A) Immunohistochemistry (IHC) reveals no differences in Iba1+ cell
content; however, more amoeboid Iba1+ cells were found in athymic
mice. (∗) P = 0.0123; (ns) not significant (P≥ 0.05). Bars, 40 µm. (B)
Immunostaining of Cx3cr1+/GFP and Ccr2+/RFP mouse brain stems re-
veals colocalization of Iba1 and GFP/RFP. Bars, 20 µm. (C ) Reduced
Nos2 ([∗∗∗∗] P < 0.0001), Tnf ([∗∗] P = 0.0051), Arg1 ([∗∗∗] P = 0.0007),
Il10 ([∗∗] P = 0.0084), Tmem119 ([∗] P = 0.0325), Cx3cr1 ([∗∗∗∗] P <
0.0001), and Ccr2 expression was observed in athymic mouse brain






Figure 2. Reduced microglia/macrophage gene expression in athy-
mic mice. (A) Reduced Nos2 ([∗] P = 0.0138), Tnf ([∗] P = 0.013), Arg1
([∗∗∗] P = 0.0008), Il10 ([∗∗] P = 0.0095), Tmem119 ([∗] P = 0.0185),
Cx3cr1 ([∗] P = 0.0147), and Ccr2 ([∗∗∗] P = 0.0008) expression was de-
tected in athymic mouse brain CD11b+ cells. (B) No difference in
the percentages of CD11b+ cells in athymic versus wild-type mouse
brain stems was observed. Bar, 40 µm. (C ) Reduced Ifng ([∗] P =
0.0176), Cd80 ([∗∗∗] P = 0.001), and Cd86 ([∗∗] P = 0.0041) expression
was detected in CD11b+ cells isolated from athymic mouse brains.
(FC) Fold change. (D) Reduced Tnfα ([∗] P = 0.0464) and Il10 ([∗] P =
0.0107) was detected following LPS stimulation in athymic mouse
brain microglia/macrophages. (E) Representative confocal images
(left) of Iba1+ cells (green) and latex beads (blue) in mouse brain slices,
with three-dimensional reconstructions (right) shown in gray and in-
dicated by white arrows. Bars, 20 µm. (F ) A lower phagocytic index
was found in athymic mouse microglia/macrophages. No increase
in phagocytic activity was observed in athymic mice following
UDP stimulation. (∗∗∗) P < 0.001, t-test comparison with their wild-
type counterparts. (MRS) MRS2578, a UDP-P2yr6 inhibitor; (ns) not
significant (P≥ 0.05).
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exhibited reduced phagocytosis comparedwith their wild-
type counterparts (Fig. 2E,F). Whereas UDP increased
phagocytosis in wild-type microglia/macrophages, which
was blocked by the MRS inhibitor, the phagocytic index
was lower in Foxn1−/− microglia under all conditions.
Collectively, these findings establish that Foxn1−/−
brain microglia/macrophages are abnormal with respect
to morphology, gene expression, and functional proper-
ties, raising the intriguing possibility that athymic mouse
brain microglia are defective in their ability to provide a
supportive microenvironment for o-GSC engraftment.
Reduced expression of Ccr2 in athymic mouse microglia/
macrophages inhibits tumor formation
The reduction in Cx3cr1 and Ccr2 levels in athymic
mouse microglia/macrophages is interesting, since
CX3CR1 and CCR2 are critical regulators of microglia/
macrophage function relevant to malignant glioma
growth (Feng et al. 2015; Chen et al. 2017). As such,
Cx3Cr1 and Ccr2 are enriched in naïve mouse brain
microglia/macrophages (Supplemental Fig. S2A), consis-
tent with previous findings that Cx3cr1 and Ccr2 are ex-
pressed primarily by brain microglia and peripheral
macrophages, respectively (Mizutani et al. 2012). Since
we demonstrated previously that reduced Cx3cr1 expres-
sion delayed, but did not abrogate, murine Nf1 optic glio-
magenesis (Pong et al. 2013), we specifically focused on
the role of Ccr2 in o-GSC engraftment.
First, we sought to determine whether Ccr2 deficiency
results in altered brain stem microglia morphology and
gene expression. Similar to athymic mice, Ccr2−/− mice
had more amoeboid Iba1+ cells (Fig. 3A), with no change
in total Iba1+ cells (Supplemental Fig. S2B). In addition,
Nos2,Arg1, Il10, and Tmem119 expression was decreased
in the Ccr2−/− mouse brain stems relative to their wild-
type counterparts (Supplemental Fig. S2C). Second, to as-
certain whether Ccr2 is required for murine LGG forma-
tion, o-GSCs were implanted into the brain stems of
wild-type and Ccr2−/− mice. While o-GSCs formed glio-
ma-like lesions in wild-type mice 6 mo after transplan-
tation, as evidenced by an increased percentage of Ki67+
cells at injection sites, no tumors formed in Ccr2−/−
mice (Fig. 3B). The o-GSC cells were labeled with
mCherry, and mCherry+ cells were detected by immuno-
histochemistry (IHC) at sites where tumors formed (Sup-
plemental Fig. S2D). Similarly, Cx3cr1−/−Ccr2−/− mice
exhibited more amoeboid Iba1+ cells (Fig. 3C) and did
not support glioma formation following o-GSC transplan-
tation (Fig. 3D). Third, to define the requirement for Ccr2
activation in Nf1 optic glioma maintenance, Nf1flox/mut;
GFAP-Cre mice (Bajenaru et al. 2003) were treated at
3 mo of age with Ccl2-neutralizing antibodies to block
Ccr2 engagement. Following anti-Ccl2 treatment, the per-
centage of amoeboid Iba1+ cells was increased relative to
the IgG-treated control group (Fig. 3E), similar to Ccr2−/−
brain stems (Fig. 3A), without any changes in total Iba1+
cells (Supplemental Fig. S2E). Importantly, mice receiving
anti-Ccl2 antibody therapy had attenuated tumor proli-
feration (reduced BrdU+ cells) (Fig. 3F). Taken together,
these data establish that the Ccl2/Ccr2 axis is required
for murineNf1 optic gliomagenesis.
Ccl5 is necessary and sufficient for glioma formation
Tumor-associated monocytes (TAMs) can produce para-
crine factors that increase glioma growth (Solga et al.
2015; Chang et al. 2016). As such, we previously used
RNA sequencing of TAMs isolated from this particular
murine Nf1 optic glioma model to demonstrate that
microglial Ccl5 drives murine Nf1 optic glioma growth
in vivo (Solga et al. 2015). In light of the defects observed
in Foxn1−/− microglia, we therefore examined Ccl5 pro-
duction: At both the RNA and protein levels,Ccl5was re-
duced in the brain stems of athymic mice (Fig. 4A,B).
Since Ccl5 is expressed primarily by microglia/macro-
phages in nonneoplastic brains (Supplemental Fig. S3A),
Ccl5 expression was also reduced in Foxn1−/−MACS-iso-
lated brain microglia (Fig. 4C).
In order to better characterize the spectrum of potential
growth factors reduced in Foxn1−/− microglia, RNA se-
quencing of the brain stems of wild-type and athymic
mice was performed. Interestingly, only three growth
factors (Il16, Cxcl10, and Ccl8) normally expressed in
microglia/macrophages (Supplemental Fig. S3B–D) were
reduced in athymic, relative to wild-type, mouse brain
stems (Supplemental Fig. S3E). These differentially ex-
pressed genes were validated by quantitative real-time
PCR (qRT-PCR) using independently derived brain stem
tissues and MACS-isolated microglia (Supplemental Fig.
S3E). However, no similarities in the patterns of differen-
tially expressed genes between wild-type and athymic
mouse brain stems were observed relative to those report-
ed formicroglia in the setting of inflammatory or neurode-
generative diseases (Keren-Shaul et al. 2017; Krasemann
et al. 2017; data not shown).
Since Ccl5 inhibition inhibits Nf1 optic glioma growth
in vivo (Solga et al. 2015), we sought to determinewhether
Ccl5 regulates the expression of Il16, Cxcl10, or Ccl8.
Consistent with Ccl5 as a tumor microenvironment mas-
ter regulator, all three genes were decreased in Ccl5−/−,
relative to wild-type, mouse brain stems and MACS-iso-





Figure 3. Ccr2 is required for murine Nf1 optic gliomagenesis.
(A) IHC reveals more amoeboid Iba1+ cells in Ccr2−/− brain stems.
(∗∗∗) P = 0.0002. (B, top panel) IHC of wild-type brain stems implanted
with o-GSCs reveals more Ki67+ cells in the injected, relative to the
contralateral, sites. (∗) P = 0.0019. (Bottom panel) IHC ofCcr2−/− brain
stems implanted with o-GSCs shows no differences in Ki67+ cells be-
tween contralateral and injected sites. (C ) IHC reveals more amoe-
boid Iba1+ cells in Cx3cr1−/−Ccr2−/− brain stems. (∗) P = 0.0222. (D)
IHC of Cx3cr1−/−Ccr2−/− brain stems implanted with o-GSCs shows
similar Ki67+ cell content between contralateral and injected sites. (E)
IHC reveals more amoeboid Iba1+ cells in the optic nerve/chiasm of
Nf1flox/mut; GFAP-Cre mice treated with anti-Ccl2-neutralizing anti-
bodies relative to control IgG. (∗∗) P = 0.0086. (F ) Reduced numbers
of BrdU+ cells were observed in anti-Ccl2-treated, relative to IgG-treat-
ed, mice. (∗) P = 0.0164. (FC) Fold change; (ns) not significant (P≥ 0.05).
T-cell–microglia interactions drive LGG growth
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To determine whether Ccl5 is necessary for tumor for-
mation, o-GSCs were implanted into the brain stems of
Ccl5−/− mice, but no glioma-like lesions were detected
(Fig. 4D). Next, to establish sufficiency, we ectopically
expressed Ccl5-RFP or RFP (control) in o-GSCs (Fig. 4E).
Ectopic Ccl5-RFP expression increased o-GSC numbers
and BrdU incorporation but decreased cleaved caspase-3
expression in vitro (Fig. 4F–I). When RFP-Ccl5- or RFP-
expressing o-GSCs were implanted into the brain stems
of athymicmice, onlyRFP-Ccl5-expressing o-GSCs gener-
ated proliferating glioma-like lesions (Fig. 4J,K). Taken
together, these findings strongly implicate Ccl5 as a key
stromal determinant in o-GSC gliomagenesis.
T cells stimulate microglia Ccl5 production
Athymicmiceharbormutations in theFoxn1gene,which,
as a transcription factor, could potentially regulate Ccl5
expression in microglia/macrophages. However, Foxn1
RNA is not expressed in the mouse or human brain or in
MACS-isolated microglia/macrophages (Supplemental
Fig. S1D–G). The absence of Foxn1 expression in the brain
raises the intriguing possibility that T cells regulate Ccl5
expression in microglia/macrophages.
Previous studies have demonstrated that interactions
between T cells and microglia/macrophages result in the
production of chemokines/cytokines that can shape the
tumor microenvironment (Chabot et al. 1999). Using
CD3 as a pan-T-cellmarker, increasedCD3+ cells were de-
tected inmurineNf1 optic gliomas (Nf1flox/mut; GFAP-Cre
mice) (Fig. 5A) as well as within the glioma-like lesions
following o-GSC engraftment in wild-type mice. In con-
trast, CD3+ cells were not found in normal brains (Fig.
5B) or o-GSC-injected sites where no tumors formed
(Supplemental Fig. S4A). Finally, consistent with reports
describing increased numbers of T cells in sporadic hu-
man PAs (Yang et al. 2011; Griesinger et al. 2013), CD3+
cells were also observed in human NF1-PA (n = 3 tumors),
with no or only rare CD3+ cells in normal brains (Fig. 5C;
Supplemental Fig. S4B).
To determine whether T cells can stimulate athymic
mouse brainmicroglia to expressCcl5, we isolated T cells
from the spleens of wild-type mice and cocultured them
with Foxn1−/− microglia. After 24 h, CM was collected
for Ccl5 enzyme-linked immunosorbent assay (ELISA),
A B C D
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Figure 4. Ccl5 is necessary and sufficient formurine LGG tumor for-
mation. (A) Reduced Ccl5 expression was observed in athymic brain
stems. (∗) P = 0.0143. (B) Reduced Ccl5 protein levels were observed
in athymic brain stems. Ccl5−/− brain stems were used as a negative
control. (∗∗) P = 0.0093; (∗∗∗) P = 0.001. (C ) Reduced Ccl5 expression
was observed in CD11b+ cells isolated from athymic mouse brains.
(∗) P = 0.0123. (D) IHC of Ccl5−/− brain stems implanted with
o-GSCs shows no differences in Ki67+ cell content between the con-
tralateral and injected sites. (E) Increased CM Ccl5 levels were ob-
served in Ccl5-RFP-expressing, relative to RFP-expressing, o-GSCs.
(∗∗∗∗) P < 0.0001. (F ) Increased cell numbers were observed in Ccl5-
RFP-expressing, relative to RFP-expressing, o-GSCs. (∗) P = 0.0266.
(G) Increased BrdU incorporation was detected in Ccl5-RFP-express-
ing, relative to RFP-expressing, o-GSCs. (∗∗∗∗) P < 0.0001. (H,I ) Re-
duced cleaved caspase-3 (casp-3) levels were detected in Ccl5-RFP-
expressing, relative to RFP-expressing, o-GSCs following normaliza-
tion to total casp-3. (∗) P = 0.0296. (J,K ) IHC of athymic mouse brain
stems implanted with o-GSCs expressing RFP (J) or Ccl5-RFP (K ).
No differences in Ki67+ cell content were observed in the RFP-im-
planted mice between contralateral and injected sites. An increased
percentage of Ki67+ cells was observed in Ccl5-RFP-injected, relative
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Figure 5. T cells induce athymicmousemicroglia/macrophage Ccl5
expression. (A) IHC reveals increased CD3+ cells (arrowheads) in the
optic nerves/chiasm of Nf1flox/mut; GFAP-Cre (optic glioma), relative
toNf1flox/flox, mice (healthy optic nerves). (∗∗) P = 0.0025. Bar, 100 µm.
(B) IHC reveals CD3+ cells at injected glioma-like lesion-bearing sites,
but not in the contralateral sites, of wild-type mice. (n.d.) Not detect-
able. Bar, 20 µm. (C ) IHC reveals CD3+ cells in human NF1- PA but
not in the normal adjacent brain. Bar, 40 µm. (D) Wild-type T cells
were cocultured with athymic mouse brain microglia/macrophages
(m/m) followed by CM collection for enzyme-linked immunosorbent
assay (ELISA) and CD11b+ cell capture (MACS) for qRT-PCR. (E)
ELISA reveals increased Ccl5 production following exposure of athy-
mic mouse microglia/macrophages to activated, but not naïve, wild-
type T cells relative tomicroglia/macrophages alone. (∗∗∗∗) P < 0.0001.
(F ) Increased Ccl5 RNA expression was observed in CD11b+ micro-
glia/macrophages exposed to activated, but not nonactivated, wild-
type T cells. (∗∗∗∗) P < 0.0001. (G,H) Increased Ccl5 protein (G) and
RNA (H) expression in athymic mouse brain microglia/macrophages
following exposure to activated wild-type T-cell CM as well as acti-
vated wild-type T cells relative to microglia/macrophages alone.
(∗∗∗∗) P < 0.0001; (∗∗∗) P = 0.001. (FC) Fold change; (ns) not significant.
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and microglia/macrophages were captured by MACS for
Ccl5 RNA quantitation using qRT-PCR (Fig. 5D). Since
productive T-cell–microglia/macrophage interactions of-
ten require T-cell activation (Chabot et al. 1999, 2002),
T cells were activated with anti-CD3ε and anti-CD28
antibodies in vitro. Following activation, increased Ccl5
levels were detected in the CM (Fig. 5E) as well as in
MACS-isolated athymic mouse brain microglia from
these cocultures (Fig. 5F). Consistent with a model in
whichT-cell activation “educates”microglia/macrophag-
es to provide a supportive microenvironment, increased
Ccr2, Cx3cr1, Tmem119, Nos2, Tnf, and Arg1 expression
was also found in MACS-isolated Foxn1−/− brain micro-
glia/macrophages following activated T-cell coculture
(Supplemental Fig. S5A–F).
While T cells account for only 3%–7% of the immune
cells in the naïvemouse brain (Korin et al. 2017), they could
potentially interact with parenchymal cells, such as micro-
glia. Alternatively, T-cell–microglia/macrophage interac-
tions could take place outside of the brain. In this regard,
reducedCcl5 levelswere also observed in spleenmonocytes
isolated from athymic mice (Supplemental Fig. S5G), re-
vealing a more pervasive defect in Foxn1−/−monocytes.
In multiple sclerosis, T-cell activation and direct
T-cell–microglia/macrophage cell contact are both neces-
sary to induce the production of soluble mediators (e.g.,
IFNγ, IL-10, iNOS, and TNFα), which in turn alter the
local microenvironment (Carson et al. 1999; Chabot
et al. 1999; Dasgupta et al. 2002). To determine whether
T-cell activation is required for T cells to increase micro-
glial Ccl5 expression, athymic mouse brain microglia
were grown in the presence of CM from activated or non-
activated (naïve) T cells. Increased Ccl5 RNA and protein
expression was observed only in microglia cocultured
with activated, but not nonactivated, T cells (Fig. 5E,F).
T cells can primemicroglia/macrophages by direct inter-
actions (e.g., cell membrane ligand–receptor engagement)
or indirect mechanisms (e.g., secrete soluble mediators).
To ascertain whether direct cell–cell contact is required
for T cells to increase microglia/macrophage Ccl5 expres-
sion, Foxn1−/− brain microglia/macrophages were exposed
to CM collected from activated T cells. Activated T-cell
CMalonewas sufficient to increaseCcl5RNAand protein
expression from athymic mouse microglia/macrophages
to levels similar to that observed following the addition
of T cells (Fig. 5G,H). While T-cell–microglia/macrophage
interaction requires T-cell activation, but not direct cell–
cell contact, future studies will be required to define the
mechanisms underlying T-cell activation in these pediat-
ric LGGs and the soluble factors responsible for mediating
microglia/macrophage priming.
Taken together, we demonstrated that activated T cells
secrete soluble factors that stimulate microglia to express
Ccl5, which provides a supportive microenvironment for
o-GSC engraftment. These studies establish acquired
LGG-promoting defects in Foxn1−/− microglia/macro-
phages that result from a failure of T-cell “education.”
The inability of T cells to interact with microglia/macro-
phages in athymic mice may represent one barrier to
successful PA patient-derived xenograft engraftment and
the development of human preclinical LGGmodels. In ad-
dition, the instructive function of T cells in priming
microglia/macrophages to create a permissive microenvi-
ronment for glioma formation and maintenance suggests
additional therapeutic strategies that interrupt these
important tumor ecosystem interactions.
Materials and methods
Mice
One-month-old male wild-type (B6-M) and athymic (Foxn1−/−; B6NU-M)
C57BL/6 mice were purchased from Taconic Biosciences. Cx3cr1+/GFP
and Ccr2+/RFP mice (Keiko Hirose, Washington University) were inter-
crossed to generate Cx3cr1−/−Ccr2−/− and Ccr2−/− mice. Ccl5−/− mice
were purchased from the Jackson Laboratory (005090). Nf1flox/flox and
Nf1flox/mut; GFAP-Cre mice were generated as described previously (Baje-
naru et al. 2003). All mice were maintained on a C57BL/6 background
and used in accordance with an approved Animal Studies Committee
protocol.
Stem cell culture
o-GSCs and neural stem cells were isolated and cultured as described pre-
viously (Chen et al. 2015; Pan et al. 2017) and detailed in the Supplemental
Material.
Isolation of microglia/macrophages
Microglia/macrophages were isolated and cultured using an established
protocol withmodifications (Moussaud andDraheim 2010) and as detailed
in the Supplemental Material.
T-cell culture
Wild-type mouse spleens were homogenized in PBS containing 0.1% BSA
and 0.6% Na-citrate, washed, and incubated with 120 Kunitz units of
DNase I for 15 min at room temperature. Single-cell suspensions were ob-
tained by filtering through a 30-µm strainer followed by red blood cell lysis
(eBioscience, 00433357) and negative selection using the pan-T-cell isola-
tion kit II (Miltenyi Biotec, 130-095-130). T cells were grown in RPMI-1640
medium supplemented with 10% FBS and 1% P/S.
In situ phagocytosis assay
The phagocytosis assay was performed as described previously (Wendt
et al. 2017) and detailed in the Supplemental Material.
IHC
Mice were euthanized and perfused in Ringer’s solution and then in 4%
paraformaldehyde, and the brains and optic nerves/chiasmswere dissected
for IHC using primary and secondary antibodies as reported previously
(Supplemental Table S1; Chen et al. 2015) and detailed in the Supplemen-
tal Material.
Statistical analyses
Data analyses were performed using Graphpad Prism. Unpaired two-tailed
Student’s t-tests were used to determine differences between two groups.
All data are presented as mean values with standard deviation. All in vitro
experiments have at least three repeatswith similar results. The number of
biological repeats is indicated as the number of dots in the scatter plots.
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